Venture Capital

Aardvark Therapeutics' pivotal trial for Prader-Willi syndrome goes global, a key step toward commercializing its novel hunger-suppressing drug.

The eyewear giant is moving beyond frames, partnering to design custom chips. A strategic pivot to open-source hardware aims to redefine the market.

With Sir Nick Clegg and AI pioneer Yann LeCun on board, HIRO Capital's new fund is a bold bet on Europe's ability to lead in deep tech innovation.

A V2G pioneer pivots its intelligent software to compete for a massive national energy storage contract in South Korea's booming, high-stakes market.

The 2025 proxy season saw record director support as investors prioritized financials, yet dissent over executive pay signals a new battleground.

With a new patent, this biotech targets the massive orthopedics market. But can its novel fibroblast therapy overcome steep financial and clinical hurdles?

A showcase in LA reveals Hollywood's strategy to tap Korean creative power, with new IPs like 'Oh My Ghost Clients' poised for a global breakthrough.

USA Rare Earth is accelerating its timeline to mine critical minerals by two years. Can innovative tech and bold strategy break foreign supply chain dominance?

Daré Bioscience is targeting a 20M-woman market with a novel arousal cream. This is the story of its clever regulatory strategy and high-stakes bet.

Beyond webinars, ON24's G2 win and LinkedIn pact reveal a strategic shift to AI-driven data and connected campaigns in the B2B marketing tech war.

With a key FAA filing, Electra's hybrid-electric EL9 moves closer to reality, promising to bypass airports with 150-foot takeoffs and landings.

The space firm secures vital cash through a complex warrant deal, but at what cost to shareholders? All eyes are now on a critical investor vote.

Behind EVs, AI, and medical breakthroughs lies a hidden process. Discover how ion implantation shapes the chips that power our future and our trust in it.

A new partnership signals a shift towards versatile, American-made drone systems, streamlining critical missions and challenging market incumbents.

The ESA's new elite summit, iicon, replaces E3, targeting C-suites to leverage gaming tech across healthcare, finance, and media. What's at stake?

New data shows Kazia's paxalisib dismantles metastatic drivers and reignites immunity, signaling a strategic disruption in advanced breast cancer treatment.

As drone attacks paralyze European airports, an Israeli tech firm's 'soft kill' net system emerges as a key contender for NATO's defense strategy.

With $47.5M and a veteran CEO, PsiThera is using its advanced AI platform to develop oral medicines for diseases long-dominated by injectable biologics.

Professor Youmin Xi's recent honor signals more than academic success. It marks a strategic blueprint for cultivating the next generation of life science leaders.

A global service provider has cracked the code on talent retention. What can the defense and aerospace sectors learn from its people-first strategy?